CLINICAL_TRIALS
trial_result
· 2023-03-02
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Ichthyosis [Phase 2]
Summary
Phase 2 trial evaluating imsidolimab for ichthyosis was terminated and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Vanda Pharmaceuticals | Conditions: Ichthyosis | Phase 2 | Status: TERMINATED | Results posted: 2023-03-02